A. Pérez

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

M. Piccart, G. Hortobagyi, J. Baselga, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

TLI in pediatric patients

R. Morera, L. Glaría, C. Ferrer, 2019, Clinical and Translational Oncology.

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

P. Neven, M. Piccart, G. Hortobagyi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.

J. Bourhis, J. Cosset, G. Socié, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer

Brant A. Inman, B. Inman, Alejandro Sousa, 2014, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

J. Bourhis, J. Cosset, G. Socié, 2001 .

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

M. Piccart, G. Hortobagyi, J. Baselga, 2014 .

Simple template-based optimization for pediatric total lymphoid irradiation (TLI) radiotherapy treatments.

C. Ferrer, A. Ocanto, P. Monja, 2020, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.